Fierce Pharma Feature: Small molecule biomarkers in precision medicine

This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.

Metabolomics: small molecules that matter more - Molecular Omics (RSC Publishing) DOI:10.1039/D0MO00176G

Bridging the preclinical to clinical divide: practical considerations for biomarker success

Overview Archives - Sapient, Discovery Metabolomics Lab, Small Molecule Biomarkers - Sapient

CPHI: In Pharma Services, Where Have All the Entrepreneurs Gone? (webinar)

Next in Precision Medicine: Small Molecule Biomarkers to Personalize Therapy

EGFR Leaders in Pharmaceutical Business Intelligence (LPBI) Group

The expanding role for small molecules in immuno-oncology

AI Drug Discovery: Key Trends and Developments in Pharma Industry

Systems biology, information, disease and drug discovery - Drug Discovery World (DDW)

CPHI: ESG Risks in Pharma and Biotech – How to Manage your Exposure (webinar)

Cancers, Free Full-Text

Fierce Biotech's 2022 Fierce 15

Molecules imagined using advanced artificial intelligence show promising results in pre-clinical experiments

Sensing Biomarkers with Plasmonics